Dimethyl sulfoxide therapy in severe retardation in monogoloid children.
D000223:Adaptation, Psychological; D000293:Adolescent; D000367:Age Factors; D000596:Amino Acids / Q000627:therapeutic use; D001722:Birth Order; D002648:Child; D002657:Child Development; D002675:Child, Preschool; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use*; D004314:Down Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007360:Intelligence; D007804:Language Development; D008297:Male; D009048:Motor Skills / Q000187:drug effects; D009132:Muscles / Q000503:physiopathology; D011594:Psychometrics; D012679:Sense Organs / Q000187:drug effects; D012959:Socioeconomic Factors
D000596:Amino Acids; D004121:Dimethyl Sulfoxide